Diabetes→IPF Research (10)
10 papers in the Diabetes→IPF topic, indexed by PF-Atlas from PubMed and global journals.
- Sodium-glucose cotransporter 2 inhibitors facilitate cell phenotype conversion of alpha cells through progenitors to beta cells by activating Ppargc1α in diabetic mice. · Chinese medical journal · 2026
- Gut Microbiota-Tryptophan Metabolism-GLP-1 Axis Participates in β-Cell Regeneration Induced by Dapagliflozin. · Diabetes · 2024
- Drugs stimulating insulin secretion in early clinical development for the treatment of type 1 diabetes: what's new? · Expert opinion on investigational drugs · 2024
- Cycling alpha cells in regenerative drug-treated human pancreatic islets may serve as key beta cell progenitors. · Cell reports. Medicine · 2024
- Glucagon Acting at the GLP-1 Receptor Contributes to β-Cell Regeneration Induced by Glucagon Receptor Antagonism in Diabetic Mice. · Diabetes · 2023
- Combined Treatment with Bone Marrow-Derived Mesenchymal Stem Cells and Exendin-4 Promotes Islet Regeneration in Streptozotocin-Induced Diabetic Rats. · Stem cells and development · 2021
- Dapagliflozin promotes beta cell regeneration by inducing pancreatic endocrine cell phenotype conversion in type 2 diabetic mice. · Metabolism: clinical and experimental · 2020
- Targeted pharmacological therapy restores β-cell function for diabetes remission. · Nature metabolism · 2020
- GLP-1 receptor agonists synergize with DYRK1A inhibitors to potentiate functional human β cell regeneration. · Science translational medicine · 2020
- A synopsis of factors regulating beta cell development and beta cell mass. · Cellular and molecular life sciences : CMLS · 2016
Medical disclaimer. Research listings are for information only and are not medical advice.